Skip to main content
Equibles

PRFX · PRF Technologies Ltd.

Track PRFX — free

Use PRFX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRFX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.86 -0.07 (-7.27%) At close · Sep 11
Rebalance outlook locked
Market Cap
$3.01M
Shares
3.50M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.86 Open$0.91 Day$0.85–0.93 Since split$0.86–3.46 Avg vol 30d295K Short int47K · 1.3% float · 1.0d Short vol42% DataFeb 2026–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Feb 6, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Feb 6, 2026.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-30,129.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+368.7%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.3%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −21%
below
RSI (14) 34
neutral
MACD trend Positive
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −28%
trailing
6-month return −62%
trailing
Relative strength −80%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+100% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.34% of float · ▼ -76.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
8 holders — near 3-yr high, broad support
Squeeze score 26
low risk · 0–100
Fundamentals
Fair
EPS growth +93%
Y/Y
Free cash flow $-4.0M
Quant / Vol
risk profile
Very High
Volatility 217%
annualized · 1-yr
Max drawdown −75%
past year
ATR 9.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−21% Bearish
RSI (14)
34 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+100% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.34% of float · ▼ -76.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
8 holders — near 3-yr high, broad support
Price context
position in its range since split · 2026-02-06
Range low $1 Now $1 · 0% Range high $3
vs 50-day avg -21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PRFX
PRF Technologies Ltd.
this stock
$3.01M — — — 1.3%
TAK
Takeda Pharmaceutical Co Ltd
 $58.31B +17.1% — — 0.1%
GALDY
Galderma Group AG/ADR
 $44.03B -8.9% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $43.22B +18.8% +4.3% 60.8 3.2%
HLN
Haleon plc
 $40.41B -9.1% — — 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
8
% held
5.8%
Net QoQ
+187.8K sh
Top holder
Yorkville Advisors Global…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
47.0K
Days to cover
1.0d
Change
-153.7K sh
View
Short Volume
Short vol %
42%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
306.4K
Value
$367.6K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
61.8%
Week of
Aug 3, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$17.0K
Net income (FY)
$-5.0M
EPS diluted
$-7.47
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 9, 2026
This year
25
View
Exempt Offerings
Offering
$6.0M
Filed
Mar 19, 2021
View

Performance

Raw-price comparisons begin at the captured split on Feb 6, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
PRFX -12.2% -28.3% -62.3% -9.8% —
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -11.0% -26.6% -80.1% -9.4% —
Key facts CIK 1801834 CUSIP M77798201 13F (30d) 4 filings 4 filers Visit website